Home > Blog
FridayDec 28, 2007 5:27 am

StockGuru Trade Alert: Guru Profile Web2 Corp. (WBTO) Up Over 23% Friday Morning

StockGuru Trade Alert: Guru Profile Web2 Corp. (WBTO) Up Over 23% Friday MorningStockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 453-4268. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated up to $16,000 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the…

Continue Reading

FridayDec 28, 2007 5:27 am

StockGuru Blog: Silver Falcon Mining (SFMI) – The Secret’s OUT and Stock Guru is Letting YOU KNOW FIRST!

Stock Guru Profile News Blogs Under the Radar Report: SFMI Gold Mines are a pure gold play. Looking for a good one? Their chart says it all. THE price of gold is to remain high in 2008, putting it on track to break $US1000 an ounce for the first time as it offers investors a safe haven from volatile finance markets and supply remains tight. In 2008, gold is tipped to top a 28-year high of $US850 in the first quarter as finance market jitters prevail and may even reach $US1100 by December 2008, some analysts have predicted. You can…

Continue Reading

FridayDec 28, 2007 5:27 am

StockGuru Trade Alert: Profile Stock LLSR Up as much as 34% Today in Very Heavy Trading

StockGuru Trade Alert:  Profile Stock LLSR Up as much as 34% Today in Very Heavy TradingThursday’s close:  $0.28 Today’s High:  $0.39 Volume is already TWICE the Ten Day Average About Lantis Laser Inc.: Lantis Laser Inc. (OTC: LLSR) is focused on developing its exclusive OCT Dental Imaging System™ for use in general dentistry under License from Lawrence Livermore National Laboratory and LightLab Imaging. Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. The Company plans to launch the OCT Dental Imaging System™…

Continue Reading

FridayDec 28, 2007 5:27 am

StockGuru Stocks to Watch for Friday, December 28, 2007 Featuring Healthnostics, CommercePlanet, American Capital Partners, Universal Energy, and Silver Falcon Mining

Healthnostics, Inc. (OTC: HNSO) Healthnostics, Inc. (OTC: HNSO) - Thursday’s shares decreased 20% to $0.008. 344,000 shares were traded. Healthnostics, Inc. announced on December 19th the completion of the MedNets.com acquisition, an Internet portal providing healthcare information resources to consumers and professionals. Healthnostics now has three well established healthcare portals providing a solid foundation for future revenue growth from advertising, affiliate marketing and industry sponsorships. This acquisition joins the MedBioWeb division’s consumer healthcare portal, FamilyMedicalNet.com, and further compliments the MedBioWorld.com internationally focused medical and biotechnology professional information portal. Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient…

Continue Reading

FridayDec 28, 2007 5:04 am

Samaritan Pharmaceuticals, Inc. (SPHC.OB) Anticipates Continued Growth in 2008

Samaritan Pharmaceuticals, Inc. (SPHC.OB), a leading biopharmaceutical company, announced that corporate management have proven their ability to successfully lead the company when faced with the daunting task of commercializing breakthrough drugs. As a result, Samaritan's 2008 outlook is projected to be stronger then that witnessed during previous years. During the year 2007, Samaritan remained focused on developing and commercializing innovative therapeutic drugs. The Company made considerable progress when advancing their late stage HIV drug through two Phase II clinical trials; in addition to advancing their memory restoring Alzheimer's drug. Samaritan has also made considerable progress when further developing their new…

Continue Reading

FridayDec 28, 2007 5:02 am

Shiming U.S, Inc (SGUS.OB) Announces Third Quarter 2007 Results

Shiming U.S., Inc. (SGUS.OB), a rapidly developing consumer electronics maker, announced their financial results for the third quarter ending September 30, 2007. Third Quarter 2007 Results were significant, as: -- Revenues increased 171 percent, from $1.1 million to $2.9 million -- Net income doubled, increasing by $363,000 to $696,000 -- Earnings per share increased 259 percent year over year to 1.04 cents from .29 cents -- Total operating expenses decreased 23.4 percent to $0.4 million from $0.5 million year over year The positive growth of the company directly correlates to increasing consumer demands for Shiming's product's. As a result, the…

Continue Reading

FridayDec 28, 2007 5:01 am

Nutra Pharma Corp (NPHC.OB) Expands Licensing Agreement to Include Environmental Testing for Nontuberculous Mycobacterium

Nutra Pharma Corp. (NPHC.OB), a biotechnology company focused on developing drugs for HIV and Multiple Sclerosis, announced that the company has expanded their licensing agreement with NanoLogix, Inc. ( NNLX.PK). Consequently, this agreement will now include the exchange of intellectual property for the testing of NonTuberculous Mycobacterium treatments. NonTuberculous Mycobacterium, also known as atypical Tuberculosis, is a bacterium that is found in water, including hot tubs and showers, some domestic and wild animals, and soil. One of the most common forms of NTM infections found in humans is Mycobacterium avium complex a leading cause of respiratory disease and a leading…

Continue Reading

ThursdayDec 27, 2007 7:08 pm

AmeriChip International, Inc. (ACII.OB) Appoints John Rehfeld to the Board of Advisors

AmeriChip International, Inc. (ACII.OB) announced that John Rehfeld has joined the company's board of advisors. Throughout John Rehfeld's career, he has often focused on advising various companies about necessary marketing measures to raise corporate profitability. In addition to this daunting task, John has over 30 years of software, content and hardware experience in the PC, digital imaging and multi-media industry. Furthermore, Mr. Rehfeld has significant Board of Director experience - serving as an outside board member for four public companies and 12 private companies. John was involved in the sale of six of these sixteen companies. John's professional background includes…

Continue Reading

ThursdayDec 27, 2007 7:06 pm

Platina Energy Group (PLTG.OB) Announces Proven Reserves that Exceed $3 Per Share

Platina Energy Group, Inc. (PLTG.OB) reported that the company's estimated proven oil reserves have doubled in value since early 2007. This increase in oil reserve value reflects a potential share appreciation by more than 35%, translating into a fair market price exceeding $3 per share. Blair Merriam, PLatina's CEO, stated, "It will be up to the market place and shareholders to determine the hidden potential of the Company's value and to make informed investment decisions. As reported by the Wall St Journal on Saturday, Oil-price prognosticators, bruised after an unusually volatile spell in the oil patch, have reached a rough…

Continue Reading

ThursdayDec 27, 2007 7:05 pm

Exelgen Ltd (CBTE) Announces Partnerships with Two Leading European Biotechnology Companies

Exelgen Ltd, a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), announced that the company has partnered with two leading European-based Biotechnology companies. However, because of the proprietary nature of this collaboration, both companies have declined to be identified or disclose the contract values. Because both companies are focused on a plethora of research activities, this partnership was advantageous for Exelgen. Such research activities include medicinal chemistry research and changes to Exelgen's LeadHopping technology. Mark Warne, Managing Directer of Exelgen, specified, "The decision by these premiere biotechnology companies to select Exelgen as their drug discovery partner underscores the quality of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .